Risk Assessment and Occupational Health: Overview and Recommendations

Levy B. S. Wegman D. H. , “Occupational Health in the United States: An Overview.” In: Levy B. S. and Wegman D. H. (eds.) Occupational Health; Recognizing and Preventing Work-Related Disease. Boston, Ma.: Little Brown and Company, 1988.

Ashford N. A. Caldart C. C. (eds) Technology, Law and the Working Environment. New York, N. Y.; Van Nostrand Reinhold, 1991.

Monson R. R. Occupational Epidemiology. Boca Raton, Fl., CRC Press, 1990.

Goodman G. Wilson R. “Quantitative Prediction of Human Cancer Risk From Rodent Carcinogenic Potencies: A Closer Look at the Epidemiological Evidence for Some Chemicals Not Definitively Carcinogenic in Humans” Regul. Toxicol. Pharmacol. 14(2): 118–146, 1991.

Millar J. D. “Summary of Proposed National Strategies for the Prevention of Leading Work-Related Diseases and Injuries, Part I,” Am. J. Ind. Med. 13: 223, 1988.

Wegman D. H. Christiani D. C. “Respiratory Disorders.” In: Levy B. S. Wegman D. H. (eds.) Occupational Health. Recognizing and Preventing Work-Related Disease. Boston, Ma.; Little, Brown and Co., 1988.

Silbergeld E. K. Landrigan P. J. Froines J. R. Pfeffer R. M. “The Occupational Lead Standard: A Goal Unachieved, A Process in Need of Repair.” New Solutions 1: 20–30, 1991.

Baker E.L. “Neurologic and Behavioral Disorders.” In: Levy B. S. Wegman D. H. (eds.) Occupational Health. Recognizing and Preventing Work-Related Disease. Boston, Ma: Little, Brown and Co., 1988.

Hatch M. C. Stein Z. A. , “Reproductive Disorders.” In: Levy B. S. Wegman D. H. (eds.) Occupational Health. Recognizing and Preventing Work-Related Disease. Boston, Ma: Little, Brown and Co., 1988.

Hass J. F. Schottenfeld R. “Risks to the Offspring from Parental Occupational Exposures. J. Occup Med. 21: 607–615, 1979.

Rosenberg M. J. Feldblum P. J. Marshall E. G. “Occupational Influences on Reproduction: A Review of the Recent Literature.” J. Occup Med. 29: 584–598, 1987.

Curran W. J. “Dangers for pregnant women in the workplace.” New Engl. J. Med. 312: 164–165, 1985.

Theriault G. P. “Cardiovascular Disorders”, In: Levy B. S. Wegman D. H. (eds.) Occupational Health. Recognizing and Preventing Work-Related Disease, Boston, Ma: Little, Brown and Co. pp 431–441, 1988.

Pirkle J.L. Schwartz J. Landis R , and Harlan W. R. “The Relationship between blood lead levels and blood pressure and its cardiovascular risk implications.” Amer J Epidemiol. 121: 246–258, 1985.

Monson R. R. “Occupation and Cancer” In Occupational Epidemiology, Boca Raton, Fl: CRC Press, 1990.

Doll R. Peto R. “The Causes of Cancer Quantitative Estimates of Avoidable Risks of Cancer in the United States Today.” J. Natl. Cancer Institute. 66: 1191–1308, 1982.

Cole P. “Cancer and Occupation: Status and Needs of Epidemiologic Research.” Cancer 39: 1788–1791, 1977.

Brandt-Rauf P. W. preface, In: Brandt-Rauf P. W. (ed.), Occupational Cancer and Carcinogenesis. Occupational Medicine, State of the Art Review. Philadelphia, Pa.; Hanley and Belfus, Inc., 1987.

Occupational Safety and Health Administration, “Occupational Exposure to 1,3-Butadiene: Proposed Rule and Notice of Hearing,” Federal Register, vol. 55, no. 155, August 10, 1990.

Occupational Safety and Health Administration, “Occupational Exposure to 4,4′-Methylenedianilline (MDA): Proposed Rule, Federal Register, Vol. 54 no. 91, 20672–20744, May 12, 1989.

Millar J. D. “Risk Assessment. A Tool to be Used Responsibly,” presented to the American Mining Congress Session on Occupational Safety and Health, New Orleans, LA, 1990.

Committee on the Institutional Means for Assessment of Risks to Public Health, Commission on Life Sciences, National Research Council, Risk Assessment in the Federal Government: Managing the Process. Washington, D.C.: National Academy Press, 1983.

Evans J. S. Graham J. D. Gray G. M. Hollis A. Ryan B. Smith A. Smith M. Taylor A. “Summary of Workshop to Review an OMB Report on Regulatory Risk Assessment and Management.” Risk: Issues in Health and Safety, 3: 77–83, 1992.

U.S. Office of Management and Budget. “Current Regulatory Issues in Risk Assessment and Risk Management,” Regulatory Program of the United States, April 1 — March 31, 1991.

Ames B. “The Detection of Chemical Mutagens with Enteric Bacteria, In: Hollaender A. (ed.), Chemical Mutagens, New York Plenum Press, 1971.

Huff J. Haseman J. Rall D. “Scientific Concepts, Value, and Significance of Chemical Carcinogenesis Studies.” Annu. Rev. Pharmacol. Toxicol. 31: 621–652, 1991.

Travis C. C. (ed), Carcinogen Risk Assessment, New York: Plenum Press, 1988.

Crump K. S. “An improved procedure for low-dose carcinogenic risk assessment from animal data. J Envir. Pathol. Toxicol. 5: 339–346, 1981.

US Environmental Protection Agency. “Guidelines for Carcinogenic Risk Assessment.” Federal Registrar 51(185), CFR 2984, No. 185 (Sept. 24) pp. 33,992–34,003. 1986.

Portier C. J. Kaplan N. L. “Variability of Safe Dose Estimates When Using Complicated Models of the Carcinogenic Process. A Case Study: Methylene Chloride.” Fundamental and Applied Toxicology 13: 533–544, 1989.

Finkel A.M. “Confronting Uncertainty in Risk Management: A Guide for Decision Makers,” Center for Risk Management, Resources for the Future, Washington, D.C., 1990.

Hoel D. G. Kaplan N. C. Andersen M. W. “Implications of Non-linear Kinetics on Risk Estimation in Carcinogenesis.” Science 219: 1032–1037, 1983.

Paustenbach D. J. Jernigan J. D. Finley B. L. Ripple S. R. Keenan R. E. “The Current Practice of Risk Assessment: Potential Impact on Standards for Toxic Air Contaminants.” J. Air Waste Mgm Assoc. 40: 1620–1630, 1990.

Matula T. I. Somers E. “The Classification of Chemical Carcinogens” Regul. Tox Pharmac. 10: 174–182, 1989.

Ashby J. Johannsen F. R. Raabe G. K. “A Scheme for Classifying Carcinogens.” Regul. Tox. Pharmac. 12: 270–295, 1990.

Ames B. N. Magaw R. Gold L. S. “Ranking Possible Carcinogenic Hazards.” Science. 236: 271–280, 1987.

Doull J Bruce M. C. “Origin and Scope of Toxicology.” In: Klaassen C. D. Amdur M. O. Doull J. (eds) Toxicology. The Basic Science of Poisons. New York: Macmillan Publishing Co., 1986.

Dourson M. L. and Stara J. F. , “Regulatory History and Experimental Support of Uncertainty (Safety) Factors,” Reg. Tox. Pharmaco. 3: 224–238, 1983.

Paustenbach D. J. “Important Recent Advances in the Practice of Health Risk Assessment: Implications for the 90's.” Regul. Tox. Pharmoco. 10: 204–243, 1989.31

Finkel A. M. “Is Risk Assessment Really Too Conservative?: Revising the Revisionists.” Colombia journal of Environmental Law 14: 427–467, 1989.

Paxman D. G. Robinson J. C. “Regulation of Occupational Carcinogens Under OSH's Air Contaminants Standard.” Regul. Tox. Pharmacol. 12: 296–308, 1990.

Industrial Union Department AFL-CIO vs. American Petroleum Institute, 448 U.S. 607, 1980. American Textile Manufacturers Association vs. Donovan, 452 U.S. 490, 495, 1980.

Travis C. C. Richter S. A. Crouch E. A. C. Wilson R. Klema E. D. “Cancer Risk Management” Environ. Sci. Technol. 21: 415–420, 1987.

Travis C. C. Hattemer-Frey H. A. “Determining an Acceptable Level of Risk.” Environ. Sci. Technol. 22: 873–876, 1988.

Hattis D. Erdreich L. Ballew M. , “Human Variability in Susceptibility to Toxic Chemicals — A Preliminary Analysis of Pharmocokinetic Data from Normal Volunteers.” Risk Analysis 7: 415–426, 1987.

Brain J. D. Beck B. Warren A. J. Shaikh R. A. (eds.) Variations in Susceptibility to Inhaled Pollutants. Identification, Mechanisms and Policy Implications. Baltimore, Md.: Johns Hopkins University Press, 1988.

Finkel A. M. “Uncertainty, Variability and the Value of Information in Cancer Risk Assessment.” Doctoral Thesis, Harvard University, Boston, MA., 1987.

Malkin D. F. Li P. Strong L. C. Fraumeni J. F. Nelson C. E. Kim D. H. Kassel J. Gryka M. A. Bischoff F. Z. Tamsky M. A. Friend S. H. “Germ-line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas and Other Neoplasms.” Science 250: 1233–1250, 1990.

Nichols A. L. and Zeckhauser R. “The Perils of Prudence: How Conservative Risk Assessments Distort Regulation.” Reg. Tox. Pharmacol 8: 61–75, 1988.

Bailar J. C. III Crouch E.A.C. Shaikh R. Spiegelman D. , “One-hit Models of Carcinogenesis: Conservative Or Not?” Risk Analysis, 8: 485–497, 1988.

Sielken R. L. , “Driving Cancer Dose-Response Modeling With Data, Not Assumptions,” Risk Analysis 10: 207–208, 1990.

Park C. N. , “Underestimation of Linear Models.” Risk Analysis 10: 209–210, 1990.

Bailar J. C. III Crouch E.A.C. Spiegelman D. Shaikh R. , “Response to Park,” Risk Analysis 10: 211–212, 1990.

Tomatis L. Aitio A. Wilbourn J. Shuker L. “Human Carcinogens So Far Identified.” Jpn. J. Cancer Res. 80: 795–807, 1989.

Fingerhut M. A. Halperin W. E. Marlow D. A. “Cancer Mortality in Workers Exposed to 2,3,7,8-terachlorodibenzo-p-dioxin.” New Engl. J Med. 324: 212–218, 1991.

Apostolou A. “Relevance of Maximum Tolerated Dose to Human Carcinogenic Risk.” Regul. Tox. Pharm. 11: 68–80, 1990.

Haseman J. K. “Issues in Carcinogenicity Testing: Dose Selection.” Fund. Appl. Tox. 5: 66–78, 1985.

Gold L. S. Backman G. M. Hooper N. K. Peto R. “Ranking the Potential Carcinogenic Hazards to Workers from Exposures to Chemicals That Are Tumorogenic in Rodents.” Envir. Hlth. Perspectives 76: 211–219, 1987.

Cohen S. M. Ellwein L B . “Generic Errors, Cell Proliferation and Carcinogenesis.” Cancer Res. 15(24): 6493–6505, 1991.

Pitot H. C. Dragan Y. P. Neveu M. J. “Chemicals, Cell Proliferation, Risk Estimation and Multistage Carcinogenesis.” Prog. Clin. Biol. Res. 369: 517–532, 1991.

Hashimoto D. H. Brennan T. Christiani D. C. “Should Exposure to Asbestos in Buildings be Regulated on an Occupational or Environmental Basis.” Ann. NY Acad Sci, 1992 (in press).

Almeder R. F. Humber J. M. “Quantitative Risk Assessment and the Notion of Acceptable Risk.” In Almeder R. E. Humber J. M. (eds.) Quantitative Risk Assessment, Biomedical Ethic Reviews, 1986. Clifton, N.J.: Humana Press, 1986.

Slovic P. “Perceptions of Risk.” Science 236: 280–285, 1987.

Drake K. Wildavsky A. “Theories of Risk Perception: Who Fears What and Why,” Daedalus 119: 41–60, 1990.